Both men and women with BRCA2 mutations also appear to have increased risks of gastric cancer (Buckley et al., 2022), pancreatic cancer (McGarry et al., 2022) and melanoma (Toussi et al., 2020). The gene discussed is BRCA2; the disease is familial pancreatic carcinoma.